Free Trial

Genpact (G) Stock Forecast & Price Target

Genpact logo
$42.19 -0.11 (-0.26%)
(As of 12/20/2024 05:16 PM ET)

Genpact - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
8
Buy
1

Based on 9 Wall Street analysts who have issued ratings for Genpact in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 8 have given a hold rating, and 1 has given a buy rating for G.

Consensus Price Target

$42.33
0.34% Upside
According to the 9 analysts' twelve-month price targets for Genpact, the average price target is $42.33. The highest price target for G is $55.00, while the lowest price target for G is $33.00. The average price target represents a forecasted upside of 0.34% from the current price of $42.19.
Get the Latest News and Ratings for G and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Genpact and its competitors.

Sign Up

G Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
8 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$42.33$42.33$38.78$40.13
Forecasted Upside0.34% Upside-8.35% Downside-0.62% Downside16.00% Upside
Consensus Rating
Hold
Hold
Hold
Hold

G Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

G Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Genpact Stock vs. The Competition

TypeGenpactBusiness Services CompaniesS&P 500
Consensus Rating Score
2.11
2.69
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside0.34% Upside169.91% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent G News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/11/2024Needham & Company LLC
2 of 5 stars
 Boost TargetBuy ➝ Buy$42.00 ➝ $55.00+19.72%
11/8/2024TD Cowen
5 of 5 stars
 Boost TargetHold ➝ Hold$40.00 ➝ $45.00-2.79%
11/8/2024Robert W. Baird
2 of 5 stars
 Boost TargetNeutral ➝ Neutral$44.00 ➝ $48.00+14.70%
9/9/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$35.00 ➝ $40.00+2.59%
9/6/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$35.00 ➝ $43.00+11.98%
8/12/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$38.00 ➝ $42.00+14.25%
Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available 
5/10/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral ➝ Neutral$35.00+3.06%
4/22/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$36.00 ➝ $33.00+4.70%
1/30/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$40.00+9.98%
8/10/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$48.00 ➝ $37.00-2.66%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:25 PM ET.


G Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Genpact is $42.33, with a high forecast of $55.00 and a low forecast of $33.00.

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Genpact in the last year. There are currently 8 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" G shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in G, but not buy additional shares or sell existing shares.

According to analysts, Genpact's stock has a predicted upside of 0.34% based on their 12-month stock forecasts.

Genpact has been rated by research analysts at Needham & Company LLC, Robert W. Baird, and TD Cowen in the past 90 days.

Analysts like Genpact less than other "business services" companies. The consensus rating for Genpact is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how G compares to other companies.


This page (NYSE:G) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners